CAT-354, an IL-13-neutralising human monoclonal antibody, inhibits airways hyperresponsiveness and eosinophilia in a cynomolgus monkey model of allergen challenge

R. D. May, E. C. Martin, P. D. Monk, N. Brennan, J. Powell, R. J. Wilson, I. K. Anderson (Cambridge, Marlborough, United Kingdom; Worcester, United States Of America)

Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Session: Regulation of the allergic and asthmatic response
Session type: Oral Presentation
Number: 1587
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. D. May, E. C. Martin, P. D. Monk, N. Brennan, J. Powell, R. J. Wilson, I. K. Anderson (Cambridge, Marlborough, United Kingdom; Worcester, United States Of America). CAT-354, an IL-13-neutralising human monoclonal antibody, inhibits airways hyperresponsiveness and eosinophilia in a cynomolgus monkey model of allergen challenge. Eur Respir J 2005; 26: Suppl. 49, 1587

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Subcutaneuous injection of monoclonal antibody anti-DEC205 conjugated with ovalbumin atenuates allergic lung inflammation of animals previously sensitized to allergen
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

Anti-IL-5 antibody reduces the increase of CD34+ eosinophils in a mouse model of airway allergic eosinophilia
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002

Anti-CD25 antibody daclizumab reduces airway eosinophilia induced by ascaris suum challenge in atopic monkeys
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008

Effect of humanized monoclonal anti-IgE antibody, omalizumab, on allergen challenge-induced nasal response in subjects with allergic rhinitis and allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 36s
Year: 2001

Induction of allergic bronchial hyperreactivity in DA-rats despite low-level eosinophilia in airways and lack of specific IgE antibodies
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma
Source: Annual Congress 2006 - Novel treatments for asthma
Year: 2006


The effects of efalizumab, an anti-CD11a monoclonal antibody (hu1124), on allergen-induced airway inflammation in atopic asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 350s
Year: 2001

Der p 2-derived peptide abrogates HDM-induced allergic asthma in mouse and humanized model
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

Effects of anti-M1 prime monoclonal antibody, MEMP1972A following allergen challenge in patients with mild asthma
Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD
Year: 2012

Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007



MEMP1972A, an anti-M1 prime monoclonal antibody, reduces serum IgE in healthy and allergic rhinitis subjects
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012

The rationale for treating allergic asthma with anti-IgE
Source: Eur Respir Rev 2007; 16: 61-66
Year: 2007



Oophorectomy decreases airway responsiveness but not eosinophilia in an ovalbumin sensitization murine model of allergy
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006


Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008

Budesonide-induced decrease of IL-5 production does not affect allergen-induced bronchoconstriction or AHR in a novel guinea pig asthma model
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019

Evaluation of bronchial hyperreactivity and other functional parameters in severe asthma patients treated with anti-interleukin-5 monoclonal antibody (IL5)
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019

Intratracheal instillation of anti-CD103 does not affect allergic airway inflammation in a mouse asthma model
Source: Eur Respir J 2005; 26: Suppl. 49, 25s
Year: 2005

Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice
Source: Eur Respir J 2009; 34: 200-208
Year: 2009